NCT06438705View on ClinicalTrials.gov

99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

May 31, 2026

Conditions
Head and Neck TumorLung CancerPancreatic Cancer
Interventions
DIAGNOSTIC_TEST

SPECT-CT imaging

The subjects were intravenously injected with 99mTc labeled FAPI imaging agent, and drank 300-500ml of water after administration. SPECT-CT imaging was performed 60 minutes later

Trial Locations (1)

210006

RECRUITING

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER